Downstream process is the part of a bioprocess that include the recovery and purification of biosynthetic products. The biosynthetic products include pharmaceutical products, mainly from the natural sources such as animal tissues, plant tissues or fermentation broth. The downstream process is an essential part in the manufacturing of vaccines, antibodies, antibiotics and hormones, such as insulin and humans growth hormone. The process include filtration, solid-liquid separation and chromatography techniques that are used for quality requirements including formulation and purification.
The market of downstream processing is anticipated to grow with a significant rate in the coming years, owing to factors such as, rising R&D expenditure for biopharmaceutical companies and increasing demand for biopharmaceuticals. On other hand, patent expiration of the popular biopharmaceuticals anticipated to develop new lucrative growth opportunities for the players operating in the downstream processing market.
The “Global Downstream Processing Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global downstream processing market with detailed market segmentation by product, technique, application, end-user and geography. The global downstream processing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global downstream processing market is segmented on the basis of product, technique, application and end-user. The downstream processing market is segmented into chromatography columns and resins, filters, membrane adsorbers, single-use products and other products, by product. On the basis of technique, purification techniques, solid-liquid separation and clarification/concentration. Based on the Application, the downstream processing market is classified into Monoclonal Antibody Production, Vaccines Production, Insulin Production, Immunoglobulin Production, Erythropoietin Production and Others. The downstream processing market is categorized into biopharmaceutical manufacturers and contract manufacturing organizations, by end user segment.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global downstream processing market based on product, technique, application and end-user. It also provides market size and forecast till 2025 for overall downstream processing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America region is dominating the downstream processing market and will still retain its position in the coming years. Owing to the biopharmaceutical research and has a major market for the pharmaceuticals worldwide and the high cost of instruments are factors driving the market in North America. On the other hand, the Asia-Pacific region is expected to witness significant growth during the forecast period, with the majority of growth primarily driven by the developing R&D infrastructure, emerging academic excellence, substantial investments made by the market players and increasing government support are fuelling the growth of the market in the Asia Pacific region.
The report analyzes factors affecting downstream processing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key downstream processing manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Thermo Fisher Scientific Inc., General Electric Company, Merck KGaA, Danaher, 3M, REPLIGEN CORPORATION, Lonza, Eppendorf AG, Corning Incorporated and Sartorius Stedim Biotech S.A. among others.